Stop the mu­sic: Pub­lic health ad­vo­cates join fight to ban ‘dis­trac­tion tech­nique’ in drug ads

Pub­lic health ad­vo­cates and oth­ers want phar­ma mar­keters to stop the mu­sic in phar­ma­ceu­ti­cal drug ad­ver­tis­ing — at least dur­ing the part when risks are pre­sent­ed.

The on­go­ing ef­fort to ask the FDA to amend its reg­u­la­tions got a boost on Wednes­day from sev­er­al well-known ad­vo­ca­cy groups and in­dus­try in­di­vid­u­als, in­clud­ing Gregg Al­ton, a for­mer Gilead in­ter­im CEO and a board mem­ber for a hand­ful of biotech com­pa­nies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER